Charcot–Marie–Tooth disease (CMT) is a hereditary and progressive neurological disorder that affects the peripheral nerves. Peripheral nerves are structures that transmit movement commands to muscles and carry sensory information from the skin and joints to the brain. In CMT, the structure or function of these nerves is impaired, leading over time to muscle weakness and sensory loss.
The disease is named after the three physicians who first described it: Jean-Martin Charcot, Pierre Marie, and Howard Henry Tooth. Today, CMT is recognized as one of the most common inherited neuropathies.
Genetic Basis of Charcot–Marie–Tooth Disease
CMT occurs due to genetic variations in genes responsible for the structure of peripheral nerves. These variations may affect two main components of the nerve:
In some types of CMT, myelin damage is predominant, while in others, the axon is directly affected. As a result, nerve conduction either slows down or weakens.
To date, more than 100 genes have been associated with CMT. The most common type, CMT1A, is linked to a duplication of the PMP22 gene.
How is CMT Inherited?
CMT can follow different inheritance patterns:
These patterns directly affect how the disease is distributed within families. In some families, the disease can be clearly traced across generations, while in others it may result from a newly occurring genetic mutation.
When and How Do Symptoms Appear?
Symptoms of CMT usually begin during:
and progress slowly over time.
The most common early signs include:
Over time, small muscles in the hands may also be affected, leading to difficulties in fine motor skills.
Are Sensory Symptoms Also Seen?
Yes. CMT affects not only muscles but also sensory nerves. Therefore, the following may occur:
Sensory loss usually progresses slowly and may be noticed late by the patient.
Types of Charcot–Marie–Tooth Disease
CMT is divided into many subtypes based on clinical and genetic characteristics. The main classification includes:
Identifying the subtype is important for disease progression and genetic counseling.
How is CMT Diagnosed?
The diagnostic process usually includes several steps:
Genetic analysis can determine:
Is There a Cure?
Currently, there is no definitive cure that completely eliminates CMT. However, it is possible to reduce its effects and improve quality of life.
Does CMT Progress?
Yes, CMT is a slowly progressive disease. However:
Early diagnosis and proper follow-up can significantly slow functional decline.
Importance of Genetic Counseling
Since CMT is a hereditary disease:
genetic counseling is very important to clearly determine risks based on scientific data.
Conclusion
Charcot–Marie–Tooth disease is a genetic disorder affecting peripheral nerves, which progresses slowly but can be managed with proper follow-up. It is one of the most striking examples of how a small genetic variation can significantly impact muscle strength and mobility. Early diagnosis, informed follow-up, and a multidisciplinary approach significantly improve the quality of life of affected individuals.